PharmNet.Bund is the Drug Information Portal of Bund (Federal Government) and Laender (States) and through it an integrated, centralised drug information system develops iteratively. It provides access to the officially collated data available throughout Germany relating to the marketing authorisation/registration and supervision of medicinal products in Germany.

For Public Access

The information system contains administrative data concerning the authorisation of drugs as well as Summary of Product Characteristics (SPCs) and Patient Information Leaflets (PILs). Furthermore you can find information about:

• Drug Information System
• Pharmaceutical Brokers and Wholesaler
• Clinical Trials
• Non-interventional studies

For Companies

Pharmaceutical companies and wholesaler are able to record their data and submit it online to the federal authorities. This includes:

• Approval Exempt
• Batch Release
• Graduated plan officer
• Product information texts
• Results of clinical trials
• Sunset Clause
  
• Supply Shortages
  

• Variation Submission

  
  

For National Authorities

National authorities are able to research and record national data online. These applications are restricted to staff members of the federal authorities and are only available in German.

Cooperation

PharmNet.Bund.de is a cooperative project of the German regulatory authorities – Federal Institute for Drugs and Medical Devices (Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM)), the Paul-Ehrlich-Institut (PEI), the Federal Office of Consumer Protection and Food Safety (Bundesamt für Verbraucherschutz und Lebensmittelsicherheit (BVL)) and the Robert Koch Institute (RKI). The project will be implemented in close cooperation with the competent authorities of the Laender coordinated by the Central Authority of the Laender for Health Protection with regard to Medicinal Products and Medical Devices (Zentralstelle der Länder für Gesundheitsschutz bei Arzneimitteln und Medizinprodukten (ZLG)).